Reported 2 days ago
Investors looking for solid dividend stocks may find opportunities in Pfizer and Merck, despite recent challenges affecting their stock performances. Pfizer's promising oncology pipeline and cost-cutting efforts could facilitate a recovery, while Merck is innovating beyond its flagship drug Keytruda. Both companies have consistently increased their dividends, making them attractive options for income-seeking investors.
Source: YAHOO